Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Pulmonx (LUNG) Accumulated Depreciation & Amortization (2019 - 2024)

Pulmonx (LUNG) has disclosed Accumulated Depreciation & Amortization for 7 consecutive years, with $6.6 million as the latest value for Q3 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 11.61% to $6.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.6 million, a 11.61% increase, with the full-year FY2024 number at $5.7 million, up 17.9% from a year prior.
  • Accumulated Depreciation & Amortization was $6.6 million for Q3 2025 at Pulmonx, up from $6.3 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $6.6 million in Q3 2025 to a low of $2.0 million in Q2 2021.
  • A 5-year average of $4.5 million and a median of $4.6 million in 2023 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 58.54% in 2022, then increased 11.61% in 2025.
  • Pulmonx's Accumulated Depreciation & Amortization stood at $2.2 million in 2021, then soared by 58.54% to $3.6 million in 2022, then skyrocketed by 36.53% to $4.9 million in 2023, then increased by 17.9% to $5.7 million in 2024, then increased by 14.57% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Accumulated Depreciation & Amortization are $6.6 million (Q3 2025), $6.3 million (Q2 2025), and $5.7 million (Q4 2024).